Top Abstract Purchase Related
Home
>
Node
>
Subnode

The history of progesterone

Newton, S.J.

International Journal of Pharmaceutical Compounding 11(4): 274-277

2007

ISSN/ISBN: 1092-4221
PMID: 23974783
Document Number: 611590
Progesterone, the principal pregestational hormone of the body, is metabolized and produced in the corpus luteum via conversion of pregnenolone. Progesterone functions to prepare the uterus for the reception and development of the fertilized ovum by transformation of the endometrium from the proliferative to the secretory stage. By suppressing menstruation and uterine contractility, progesterone is extremely important in the maintenance of pregnancy. The two most frequent uses for progestins are contraception and hormone replacement therapy. This article provides a brief history of the discovery of progesterone and its therapeutic development and discusses the major challenges and advancements in steroid chemistry.

Document emailed within 1 workday
Secure & encrypted payments

Roche, J.F.; Gosling, J.P. 1977: Control of estrus and progesterone levels in heifers given intravaginal progesterone coils and injections of progesterone and estrogen Journal of Animal Science 44(6): 1026-1029
Anonymous 2000: Progestins, Progesterone Receptor Modulators, and Progesterone Antagonists. Progesterone, progestins and antiprogestins in the next millennium, Jerusalem, Israel, 31 August-3 September, 1999 Steroids 65(10/11): 543-850
Choe, J.K.; Check, J.H.; Nowroozi, K.; Benveniste, R.; Barnea, E.R. 1992: Serum progesterone and 17-hydroxyprogesterone in the diagnosis of ectopic pregnancies and the value of progesterone replacement in intrauterine pregnancies when serum progesterone levels are low Gynecologic and Obstetric Investigation 34(3): 133-138
Richardson, A.P.; Kim, J.B.; Barnard, G.J.; Collins, W.P.; McCapra, F. 1985: Chemiluminescence immunoassay of plasma progesterone, with progesterone-acridinium ester used as the labeled antigen Clinical Chemistry 31(10): 1664-1668
Toivonen, J. 1980: Pituitary and gonadal function during the use of progesterone- or progesterone-estradiol-releasing vaginal rings International Journal of Fertility 25(2): 106-111
Dragonas, C.; Maltaris, T.; Binder, H.; Kat, M.; Mueller, A.; Cupisti, S.; Hoffmann, I.; Beckmann, M.W.; Dittrich, R. 2007: Progesterone bioavailability with a progesterone-releasing silicone vaginal ring in IVF candidates European Journal of Medical Research 12(6): 264-267
Wolf, H.; Egert, D.; Maass, H. 1973: Progesterone binding protein and the influence of corticosteroids on the uptake of progesterone by the rat uterus Acta Endocrinologica. Supplementum 173: 68
Pouly, J.L.; Bassil, S.; Frydman, R.; Hédon, B.; Nicollet, B.; Prada, Y.; Antoine, J.M.; Zambrano, R.; Donnez, J. 1997: Luteal phase support after vaginal progesterone: comparative study with micronized oral progesterone Contraception Fertilite Sexualite 25(7-8): 596-601
Eremin, A.N.; Metelitsa, D.I. 1989: Catalytic activity of conjugates of peroxidase with progesterone in aqueous and micellar media in the presence of antibodies against progesterone Bioorganicheskaia Khimiia 15(10): 1326-1333
Keltz, M.D.; Stein, D.E.; Berin, I.; Skorupski, J. 2012: Elevated progesterone-to-estradiol ratio versus serum progesterone alone for predicting poor cycle outcome with in vitro fertilization Journal of Reproductive Medicine 57(1-2): 9-12
Wu, Z.; Wu, H.; Sun, S.; Wu, H.; Shi, W.; Song, J.; Liu, J.; Zhang, Y.; Bian, F.; Jia, P.; Hou, Y. 2020: Progesterone attenuates Aβ25-35-induced neuronal toxicity by activating the Ras signalling pathway through progesterone receptor membrane component 1 Life Sciences 253: 117360
Allen, W.M.; Ehrenstein, M. 1944: 10-Nor-Progesterone, a Physiologically Active Lower Homolog of Progesterone Science 100(2594): 251-252
Berger, U.; Wilson, P.; Thethi, S.; McClelland, R.A.; Greene, G.L.; Coombes, R.C. 1989: Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors Cancer Research 49(18): 5176-5179
Botella, J.; Duranti, E.; Viader, V.; Duc, I.; Delansorne, R.; Paris, J. 1995: Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells Journal of Steroid Biochemistry and Molecular Biology 55(1): 77-84
Saez, S.; Martin, P.M.; Chouvet, C.D. 1978: Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels Cancer Research 38(10): 3468-3473
Kofinas, A.D.; Rose, J.C.; Koritnik, D.R.; Meis, P.J. 1990: Progesterone and estradiol concentrations in nonpregnant and pregnant human myometrium. Effect of progesterone and estradiol on cyclic adenosine monophosphate-phosphodiesterase activity Journal of Reproductive Medicine 35(11): 1045-1050
Egert, D.; Maass, H. 1974: Progesterone in the uterus. 3. On the question of progesterone metabolism in the uterus of pregnant rats Acta Endocrinologica 77(1): 160-170
Egert, D.; Maass, H. 1974: Progesterone in the uterus. I. On the question of progesterone metabolism in the uterus of normal rats Acta Endocrinologica 77(1): 135-149
Smith, M. 2007: Childbirth in women with a history of sexual abuse: a case history approach Practising Midwife 10(3): 39-43
Cozzolino, G.; Lonardo, A.; Francica, G.; Lucariello, A.; Morante, R.; Cacciatore, L. 1983: The natural history of the evolutive chronic hepatopathies. Contribution of the medical history Recenti Progressi in Medicina 74(12): 1349-1359